Comparison of the Rates of Adverse Drug Reactions: Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents

Wolf GL, Mishkin MM, Roux SG, et al. Comparison of the rates of adverse drug reactionsionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26:404–410.The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Investigative radiology 1991-05, Vol.26 (5), p.404-410
Hauptverfasser: WOLF, GERALD L, MISHKIN, MARK M, ROUX, SUSAN G, HALPERN, ELKAN F, GOTTLIEB, JANIS, ZIMMERMAN, JAY, GILLEN, JOE, THELLMAN, CHERYL
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 410
container_issue 5
container_start_page 404
container_title Investigative radiology
container_volume 26
creator WOLF, GERALD L
MISHKIN, MARK M
ROUX, SUSAN G
HALPERN, ELKAN F
GOTTLIEB, JANIS
ZIMMERMAN, JAY
GILLEN, JOE
THELLMAN, CHERYL
description Wolf GL, Mishkin MM, Roux SG, et al. Comparison of the rates of adverse drug reactionsionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26:404–410.The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedication, and of a nonionic agent (iohexol) upon the frequency and severity of adverse drug reactions (ADRs) was compared in ten hospitals during three separate time periods from 1985 to 1989. Nonionic agents were found to reduce significantly total ADRs; 52 of 8857 patients receiving nonionic agents experienced reactions, versus 263 of 6006 patients for ionics (P < .0001). The frequency of reactions classed as mild (2.9% for ionic agents versus 0.476 for nonionic agentsP < .001), moderate (1.2% versus 0.1%; P < .001), or severe (0.37% versus 0.01%; P < .001), also favored nonionic agents. Steroid premedication provided some protection, but iohexol was significantly better with respect to mild reactions (2.9% versus 0.4%, P < .001), moderate reactions (0.9% versus 0.1%, P < .01), and severe reactions (0.25% versus 0.01%, P < .01). The contrast medium was the greatest risk factor for adverse reaction (odds ratio 7.3), while prior contrast reaction (odds ratio 6.25), and hay fever (odds ratio 2.3) were found to be significant independent risks. We conclude that nonionic agents are safer for intravenous use than ionic agents given alone or with corticosteroid premedication.
doi_str_mv 10.1097/00004424-199105000-00003
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1097_00004424_199105000_00003</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2055736</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3003-73b12e6b1191686b01e5f4a7923b851e447be4b7ba36e349048ee4e133e917c93</originalsourceid><addsrcrecordid>eNp1UVtLwzAUDqLMOf0JQn6A1aRJL_Ft1NtgKEx9Lkl7ulbbZiSZw1d_uZmdwxfPy-G7Bc4XhDAll5SI5Ir44TzkARWCksijYEuxAzSmEYsDElJyiMaEhCQQQsTH6MTaN-8IE8JGaBSSKEpYPEZfme5W0jRW91hX2NWAF9KB3YJp-QHGAr4x6yVegCxco3t7jWe6bwqc6d4ZaR2eLqF39mJHD8irnWp6KPGmcTV-dmB0U3qT7Ev86I1_vKfoqJKthbPdnqDXu9uX7CGYP93Psuk8KJi_LEiYoiHEilJB4zRWhEJUcZmIkKk0osB5ooCrREkWA-OC8BSAA2UMBE0KwSYoHd4tjLbWQJWvTNNJ85lTkm9bzX9bzfet_lDMR8-H6GqtOij3wV2NXueDvtGtP9W-t-sNmLwG2bo6_--z2DerFoGM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Comparison of the Rates of Adverse Drug Reactions: Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>WOLF, GERALD L ; MISHKIN, MARK M ; ROUX, SUSAN G ; HALPERN, ELKAN F ; GOTTLIEB, JANIS ; ZIMMERMAN, JAY ; GILLEN, JOE ; THELLMAN, CHERYL</creator><creatorcontrib>WOLF, GERALD L ; MISHKIN, MARK M ; ROUX, SUSAN G ; HALPERN, ELKAN F ; GOTTLIEB, JANIS ; ZIMMERMAN, JAY ; GILLEN, JOE ; THELLMAN, CHERYL</creatorcontrib><description><![CDATA[Wolf GL, Mishkin MM, Roux SG, et al. Comparison of the rates of adverse drug reactionsionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26:404–410.The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedication, and of a nonionic agent (iohexol) upon the frequency and severity of adverse drug reactions (ADRs) was compared in ten hospitals during three separate time periods from 1985 to 1989. Nonionic agents were found to reduce significantly total ADRs; 52 of 8857 patients receiving nonionic agents experienced reactions, versus 263 of 6006 patients for ionics (P < .0001). The frequency of reactions classed as mild (2.9% for ionic agents versus 0.476 for nonionic agentsP < .001), moderate (1.2% versus 0.1%; P < .001), or severe (0.37% versus 0.01%; P < .001), also favored nonionic agents. Steroid premedication provided some protection, but iohexol was significantly better with respect to mild reactions (2.9% versus 0.4%, P < .001), moderate reactions (0.9% versus 0.1%, P < .01), and severe reactions (0.25% versus 0.01%, P < .01). The contrast medium was the greatest risk factor for adverse reaction (odds ratio 7.3), while prior contrast reaction (odds ratio 6.25), and hay fever (odds ratio 2.3) were found to be significant independent risks. We conclude that nonionic agents are safer for intravenous use than ionic agents given alone or with corticosteroid premedication.]]></description><identifier>ISSN: 0020-9996</identifier><identifier>EISSN: 1536-0210</identifier><identifier>DOI: 10.1097/00004424-199105000-00003</identifier><identifier>PMID: 2055736</identifier><language>eng</language><publisher>United States: Lippincott-Raven Publishers</publisher><subject>Diatrizoate Meglumine - administration &amp; dosage ; Diatrizoate Meglumine - adverse effects ; Humans ; Injections, Intravenous ; Iohexol - administration &amp; dosage ; Iohexol - adverse effects ; Methylprednisolone - administration &amp; dosage ; Methylprednisolone - therapeutic use ; Premedication ; Risk Factors ; Urography</subject><ispartof>Investigative radiology, 1991-05, Vol.26 (5), p.404-410</ispartof><rights>Lippincott-Raven Publishers.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2055736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>WOLF, GERALD L</creatorcontrib><creatorcontrib>MISHKIN, MARK M</creatorcontrib><creatorcontrib>ROUX, SUSAN G</creatorcontrib><creatorcontrib>HALPERN, ELKAN F</creatorcontrib><creatorcontrib>GOTTLIEB, JANIS</creatorcontrib><creatorcontrib>ZIMMERMAN, JAY</creatorcontrib><creatorcontrib>GILLEN, JOE</creatorcontrib><creatorcontrib>THELLMAN, CHERYL</creatorcontrib><title>Comparison of the Rates of Adverse Drug Reactions: Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents</title><title>Investigative radiology</title><addtitle>Invest Radiol</addtitle><description><![CDATA[Wolf GL, Mishkin MM, Roux SG, et al. Comparison of the rates of adverse drug reactionsionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26:404–410.The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedication, and of a nonionic agent (iohexol) upon the frequency and severity of adverse drug reactions (ADRs) was compared in ten hospitals during three separate time periods from 1985 to 1989. Nonionic agents were found to reduce significantly total ADRs; 52 of 8857 patients receiving nonionic agents experienced reactions, versus 263 of 6006 patients for ionics (P < .0001). The frequency of reactions classed as mild (2.9% for ionic agents versus 0.476 for nonionic agentsP < .001), moderate (1.2% versus 0.1%; P < .001), or severe (0.37% versus 0.01%; P < .001), also favored nonionic agents. Steroid premedication provided some protection, but iohexol was significantly better with respect to mild reactions (2.9% versus 0.4%, P < .001), moderate reactions (0.9% versus 0.1%, P < .01), and severe reactions (0.25% versus 0.01%, P < .01). The contrast medium was the greatest risk factor for adverse reaction (odds ratio 7.3), while prior contrast reaction (odds ratio 6.25), and hay fever (odds ratio 2.3) were found to be significant independent risks. We conclude that nonionic agents are safer for intravenous use than ionic agents given alone or with corticosteroid premedication.]]></description><subject>Diatrizoate Meglumine - administration &amp; dosage</subject><subject>Diatrizoate Meglumine - adverse effects</subject><subject>Humans</subject><subject>Injections, Intravenous</subject><subject>Iohexol - administration &amp; dosage</subject><subject>Iohexol - adverse effects</subject><subject>Methylprednisolone - administration &amp; dosage</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Premedication</subject><subject>Risk Factors</subject><subject>Urography</subject><issn>0020-9996</issn><issn>1536-0210</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1UVtLwzAUDqLMOf0JQn6A1aRJL_Ft1NtgKEx9Lkl7ulbbZiSZw1d_uZmdwxfPy-G7Bc4XhDAll5SI5Ir44TzkARWCksijYEuxAzSmEYsDElJyiMaEhCQQQsTH6MTaN-8IE8JGaBSSKEpYPEZfme5W0jRW91hX2NWAF9KB3YJp-QHGAr4x6yVegCxco3t7jWe6bwqc6d4ZaR2eLqF39mJHD8irnWp6KPGmcTV-dmB0U3qT7Ev86I1_vKfoqJKthbPdnqDXu9uX7CGYP93Psuk8KJi_LEiYoiHEilJB4zRWhEJUcZmIkKk0osB5ooCrREkWA-OC8BSAA2UMBE0KwSYoHd4tjLbWQJWvTNNJ85lTkm9bzX9bzfet_lDMR8-H6GqtOij3wV2NXueDvtGtP9W-t-sNmLwG2bo6_--z2DerFoGM</recordid><startdate>199105</startdate><enddate>199105</enddate><creator>WOLF, GERALD L</creator><creator>MISHKIN, MARK M</creator><creator>ROUX, SUSAN G</creator><creator>HALPERN, ELKAN F</creator><creator>GOTTLIEB, JANIS</creator><creator>ZIMMERMAN, JAY</creator><creator>GILLEN, JOE</creator><creator>THELLMAN, CHERYL</creator><general>Lippincott-Raven Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>199105</creationdate><title>Comparison of the Rates of Adverse Drug Reactions: Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents</title><author>WOLF, GERALD L ; MISHKIN, MARK M ; ROUX, SUSAN G ; HALPERN, ELKAN F ; GOTTLIEB, JANIS ; ZIMMERMAN, JAY ; GILLEN, JOE ; THELLMAN, CHERYL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3003-73b12e6b1191686b01e5f4a7923b851e447be4b7ba36e349048ee4e133e917c93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Diatrizoate Meglumine - administration &amp; dosage</topic><topic>Diatrizoate Meglumine - adverse effects</topic><topic>Humans</topic><topic>Injections, Intravenous</topic><topic>Iohexol - administration &amp; dosage</topic><topic>Iohexol - adverse effects</topic><topic>Methylprednisolone - administration &amp; dosage</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Premedication</topic><topic>Risk Factors</topic><topic>Urography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>WOLF, GERALD L</creatorcontrib><creatorcontrib>MISHKIN, MARK M</creatorcontrib><creatorcontrib>ROUX, SUSAN G</creatorcontrib><creatorcontrib>HALPERN, ELKAN F</creatorcontrib><creatorcontrib>GOTTLIEB, JANIS</creatorcontrib><creatorcontrib>ZIMMERMAN, JAY</creatorcontrib><creatorcontrib>GILLEN, JOE</creatorcontrib><creatorcontrib>THELLMAN, CHERYL</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Investigative radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>WOLF, GERALD L</au><au>MISHKIN, MARK M</au><au>ROUX, SUSAN G</au><au>HALPERN, ELKAN F</au><au>GOTTLIEB, JANIS</au><au>ZIMMERMAN, JAY</au><au>GILLEN, JOE</au><au>THELLMAN, CHERYL</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the Rates of Adverse Drug Reactions: Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents</atitle><jtitle>Investigative radiology</jtitle><addtitle>Invest Radiol</addtitle><date>1991-05</date><risdate>1991</risdate><volume>26</volume><issue>5</issue><spage>404</spage><epage>410</epage><pages>404-410</pages><issn>0020-9996</issn><eissn>1536-0210</eissn><abstract><![CDATA[Wolf GL, Mishkin MM, Roux SG, et al. Comparison of the rates of adverse drug reactionsionic contrast agents, ionic agents combined with steroids, and nonionic agents. Invest Radiol 1991;26:404–410.The influence of ionic agents alone, of diatrizoate plus two oral doses of methylprednisolone premedication, and of a nonionic agent (iohexol) upon the frequency and severity of adverse drug reactions (ADRs) was compared in ten hospitals during three separate time periods from 1985 to 1989. Nonionic agents were found to reduce significantly total ADRs; 52 of 8857 patients receiving nonionic agents experienced reactions, versus 263 of 6006 patients for ionics (P < .0001). The frequency of reactions classed as mild (2.9% for ionic agents versus 0.476 for nonionic agentsP < .001), moderate (1.2% versus 0.1%; P < .001), or severe (0.37% versus 0.01%; P < .001), also favored nonionic agents. Steroid premedication provided some protection, but iohexol was significantly better with respect to mild reactions (2.9% versus 0.4%, P < .001), moderate reactions (0.9% versus 0.1%, P < .01), and severe reactions (0.25% versus 0.01%, P < .01). The contrast medium was the greatest risk factor for adverse reaction (odds ratio 7.3), while prior contrast reaction (odds ratio 6.25), and hay fever (odds ratio 2.3) were found to be significant independent risks. We conclude that nonionic agents are safer for intravenous use than ionic agents given alone or with corticosteroid premedication.]]></abstract><cop>United States</cop><pub>Lippincott-Raven Publishers</pub><pmid>2055736</pmid><doi>10.1097/00004424-199105000-00003</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0020-9996
ispartof Investigative radiology, 1991-05, Vol.26 (5), p.404-410
issn 0020-9996
1536-0210
language eng
recordid cdi_crossref_primary_10_1097_00004424_199105000_00003
source MEDLINE; Journals@Ovid Complete
subjects Diatrizoate Meglumine - administration & dosage
Diatrizoate Meglumine - adverse effects
Humans
Injections, Intravenous
Iohexol - administration & dosage
Iohexol - adverse effects
Methylprednisolone - administration & dosage
Methylprednisolone - therapeutic use
Premedication
Risk Factors
Urography
title Comparison of the Rates of Adverse Drug Reactions: Ionic Contrast Agents, Ionic Agents Combined with Steroids, and Nonionic Agents
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T03%3A39%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20Rates%20of%20Adverse%20Drug%20Reactions:%20Ionic%20Contrast%20Agents,%20Ionic%20Agents%20Combined%20with%20Steroids,%20and%20Nonionic%20Agents&rft.jtitle=Investigative%20radiology&rft.au=WOLF,%20GERALD%20L&rft.date=1991-05&rft.volume=26&rft.issue=5&rft.spage=404&rft.epage=410&rft.pages=404-410&rft.issn=0020-9996&rft.eissn=1536-0210&rft_id=info:doi/10.1097/00004424-199105000-00003&rft_dat=%3Cpubmed_cross%3E2055736%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2055736&rfr_iscdi=true